Company profile
BIOLARGO, INC. CIK 880242
Ticker
BLGO (OTC)
Industry
Chemicals & Allied Products
Headquarters
Westminster, CA 92683
Fiscal year end
2025 (FY)
Key Financials
Revenue
—
Net income
-$11.78M
Total assets
$8.31M
Total liabilities
$6.79M
Stockholders' equity
$4.04M
Cash & equivalents
$3.88M
Operating income
-$14.86M
Operating cash flow
-$8.30M
Capital expenditures
—
Fiscal year 2025, via 10-K filed 2026-03-04. A dash means this figure wasn't reported in the source filing under a field State Ledger recognizes - not that the value is zero.
Financial Performance
Operating margin
—
Net margin
—
Free cash flow
—
Free cash flow margin
—
Liabilities / assets
81.6%
Equity / assets
48.6%
CapEx / revenue
—
Operating cash flow / net income
0.70×
Derived from the fiscal year 2025 figures above. These metrics are mathematical calculations and do not represent a rating or assessment of the company.
Financial History
Fiscal yearRevenueNet incomeAssetsLiabilitiesEquity
2025
—
-$11.78M
$8.31M
$6.79M
$4.04M
2024
—
-$2.40M
$10.51M
$4.46M
$8.85M
2023
$12.23M
-$3.50M
$8.21M
$4.00M
$6.84M
2022
—
-$4.47M
$4.86M
$2.85M
$4.88M
2021
—
-$7.08M
$3.02M
$2.09M
$4.65M
Company Details
SIC code
2800
State of incorporation
DE
Active filer
Yes
Most recent SEC filing
Form 8-K/A
2026-09-14
Financials filed via
Form 10-K
filed 2026-03-04
"Most recent SEC filing" may differ from the filing used for the financial figures above.
Location
Westminster, CA 92683
Data & Methodology
SEC EDGAR submissions API (identity, collected Sep 19, 2026, 15:11 UTC) and SEC XBRL Company Facts API (financials, collected Sep 26, 2026, 15:14 UTC) · figures as originally filed, not restated · a dash always means a value wasn't reported, never a real zero.